PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
about
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory DiseasesNitric oxide/cGMP pathway signaling actively down-regulates α4β1-integrin affinity: an unexpected mechanism for inducing cell de-adhesion.Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preferenceClinical and molecular genetics of the phosphodiesterases (PDEs).Emerging drugs for chronic obstructive pulmonary disease.Emerging drugs for asthma.cAMP regulation of airway smooth muscle function.PDE inhibitors currently in early clinical trials for the treatment of asthma.Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.Roflumilast N-oxide prevents cytokine secretion induced by cigarette smoke combined with LPS through JAK/STAT and ERK1/2 inhibition in airway epithelial cells.Atacamycins A-C, 22-membered antitumor macrolactones produced by Streptomyces sp. C38.Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities.Response to: Oba, Y. and Lone, N. (2013) Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.Ther Adv Respir Dis 7: 13-24.Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors.Phosphodiesterase type 5 and cancers: progress and challenges.
P2860
Q26750377-4E529C37-A73F-4723-A20C-277631161313Q33903491-A7414467-E4BD-4B68-A87F-C7E198A41CC8Q36234303-717A5624-A872-4A51-B4CF-8BF6C01DE3ECQ37657841-9ADC1DE2-C7EA-45A4-B234-F79B85563299Q37984088-B97EFBF8-3D9A-4BDA-B1FE-D71F52FCDAF6Q38011270-8C07A3AA-FB30-4F9C-A2AA-E2BE8E6F894AQ38013462-35957F7C-C836-4AF9-8ADB-AE6EACDEF223Q38215280-88A508E4-8F39-486D-9380-9DE3D1467FC7Q38595360-3FFDA9E8-13C1-4A92-8BB8-DFEB51D20791Q39035070-28598C04-D285-4BF8-90CF-BB75E5D7362EQ39288985-7DCCCCF5-5268-43BB-9724-8112EC4AC8A1Q42365240-74BC4CFD-58E6-4C77-B14E-6F2714DDA066Q44209387-F191526B-9962-4374-8788-6B199A8CDA0AQ46212027-BAEFE1E6-12A9-4DC5-B38B-2F6F7874D9AAQ47171803-BF1ADBE4-10BF-4D81-B52A-B6CD33503B92
P2860
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
@en
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
@nl
type
label
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
@en
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
@nl
prefLabel
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
@en
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
@nl
P1476
PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease.
@en
P2093
Domenico Spina
Zuzana Diamant
P304
P356
10.1016/J.PUPT.2010.12.011
P577
2011-01-19T00:00:00Z